Taripho Tablet (Bepotastine Besilate)

Adult dose

Usually, adults are given 10mg of bepotastine besilate orally twice daily. The dose may be adjusted appropriately according to age and symptoms.

This medication should not be used in patients who have an allergic reaction to its components. Caution should be exercised when administering to patients with renal or hepatic dysfunction, and to elderly patients. Some individuals in clinical trials taking this medication may experience CNS symptoms such as drowsiness, headaches, dizziness, as well as gastrointestinal symptoms such as vomiting and diarrhea. Moreover, adverse reactions such as changes in blood counts, increased liver function tests, and skin rashes have been reported. Drowsiness may occur while taking this medication, so caution is advised when driving or operating dangerous machinery. Patients who have been on long-term steroid therapy should gradually taper their steroid dosage when taking this medication. For patients with poor renal function, the blood concentration of this medication may increase, so it is advisable to start with a low dose and closely monitor their condition. The use of this medication in patients with seasonal allergic rhinitis has not been sufficiently studied; thus, it should be administered with caution depending on the season and symptoms. If ineffective, it is preferable not to take it for an extended period. Like other antihistamines, it should not be taken with alcohol. Women who are pregnant or may become pregnant should avoid this medication, and if necessary, consult a doctor before taking it. Women who are breastfeeding should also be cautious since this medication can be passed through breast milk, and it is advisable to avoid it or to discontinue breastfeeding. Safety in children has not been established, so careful use is required. Elderly patients should be careful since renal function decline may increase the risk of higher drug concentrations. This medication may affect allergy tests, so it is advisable to discontinue use prior to testing. When taking the medication, the tablet should be removed from the packaging and ingested carefully to avoid swallowing the packaging. Finally, this medication should be stored out of the reach of children and kept in a sealed container away from moisture at temperatures below 30 degrees Celsius.

• Drowsiness
• lethargy
• headache
• heaviness in the head
• dizziness
• dry mouth
• dry mucous membranes
• glossitis
• nausea
• vomiting

This medication should be stored in a tightly sealed container to protect it from air and moisture, at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the efficacy and prevent degradation of the medication.

Appearance

White film-coated tablets with a score line

Package unit

30 tablets/bottle, 300 tablets/bottle